Analyst consensus rating
Anixa Biosciences Analyst Rating: Strong Buy
Direct answer
Anixa Biosciences's consensus rating is Strong Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $9.67.
Forecast evidence checked November 3, 2026.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $2.99
- Average price target
- $9.67
- High price target
- $14.00
- Low price target
- $6.00
- Low target gap
- +100.7%
- Target upside
- +223.3%
- High target gap
- +368.2%
- Target range width
- 267.6%
- Consensus rating
- Strong Buy
- Analysts
- 3
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Anixa Biosciences?
Anixa Biosciences has a verified Strong Buy consensus. The same dataset has an average price target of $9.67.
How far are Anixa Biosciences's low and high targets from the recorded price?
The low target implies +100.7%, while the high target implies +368.2%.
How many analysts are included in Anixa Biosciences's consensus?
The verified consensus includes 3 analysts.
How is Anixa Biosciences's target upside or downside calculated?
The average target of $9.67 is divided by the recorded price of $2.99, then one is subtracted to produce +223.3%. This does not guarantee a future return.
When was Anixa Biosciences's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.